drugset / Trial / NCT00102856

Neuromodulation and Language Acquisition (Stage Ib)

NCT00102856 ↗

Phase 4 Suspended 60 enrolled University Hospital Muenster
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether rivastigmine or pramipexol are effective in boosting semantic language acquisition in healthy subjects.

Timeline

Start
2005-01
Primary completion
—
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Pramipexole Unknown — —
Subject Rivastigmine Small molecule — —

Indications

No indication recorded.